CTGov Compliance My Organizations

Compliance Rate

Compliance Rate 62.5%

Compliant submissions 5

Incompliant submissions 3

Total trials 8

My Organizations' Clinical Trials

Showing 475 of 1349 entries

View as:

Immunomodulation Following Transfusion

Phase: N/A Priority: Normal

NCT ID: NCT00810810 Org: User:

Start: 07/31/06 End: 08/31/11 Due: 08/31/12

Safer Conception Intervention for HIV-1 Serodiscordant Couples

Phase: N/A Priority: Normal

NCT ID: NCT03030768 Org: User:

Start: 02/29/16 End: 07/31/18 Due: 07/31/19

Automated Real-time Feedback on CPR Study

Phase: N/A Priority: Normal

NCT ID: NCT00539539 Org: User:

Start: 02/28/07 End: 09/30/09 Due: 09/30/10

A Study on the Use of Real -Time Continuous Glucose Monitoring (RT-CGM) in Gestational Diabetes

Phase: N/A Priority: Normal

NCT ID: NCT04803357 Org: User:

Start: 04/10/21 End: 01/15/25 Due: 01/15/26

Daily Doxycycline for Early Syphillis

Phase: N/A Priority: Normal

NCT ID: NCT06683638 Org: User:

Start: 03/03/25 End: 06/26/26 Due: 06/26/27

The Nociception Level During General Anesthesia

Phase: N/A Priority: Normal

NCT ID: NCT01978379 Org: User:

Start: 10/31/13 End: 12/31/14 Due: 12/31/15

Breast Displacement and CT Radiation Dose

Phase: N/A Priority: Normal

NCT ID: NCT01261559 Org: User:

Start: 12/31/10 End: 02/29/12 Due: 02/28/13

Hormone Replacement Therapy and Prothrombotic Variants

Phase: N/A Priority: Normal

NCT ID: NCT00049933 Org: User:

Start: 09/30/02 End: 08/31/08 Due: 08/31/09

Text Messaging to Improve Adherence to Clinic Visits and Reduce Early Resumption of Sexual Intercourse After Male Circumcision

Phase: N/A Priority: Normal

NCT ID: NCT01186575 Org: User:

Start: 08/31/10 End: 06/30/11 Due: 06/30/12

Durvalumab, Tremelimumab and Hypofractionated Radiation Therapy in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

Phase: N/A Priority: Normal

NCT ID: NCT03522584 Org: User:

Start: 05/17/18 End: 01/19/22 Due: 01/19/23

Umbralisib and Pembrolizumab in Treating Patients With Relapsed or Refractory Classical Hodgkin Lymphoma

Phase: N/A Priority: Normal

NCT ID: NCT03776864 Org: User:

Start: 09/26/19 End: 09/14/21 Due: 09/14/22

Overcoming Barriers to HIV/AIDS Care and ART Initiation

Phase: N/A Priority: Normal

NCT ID: NCT02718456 Org: User:

Start: 08/31/13 End: 12/22/17 Due: 12/22/18

Motivation Matters Study

Phase: N/A Priority: Normal

NCT ID: NCT02627365 Org: User:

Start: 01/31/16 End: 08/31/18 Due: 08/31/19

Primary Care Obesity Prevention and Treatment

Phase: N/A Priority: Normal

NCT ID: NCT00944164 Org: User:

Start: 09/30/06 End: 08/31/08 Due: 08/31/09

Dental Hygiene and Peri-Implant Tissues Homeostasis

Phase: N/A Priority: Normal

NCT ID: NCT03384446 Org: User:

Start: 11/22/17 End: 06/10/23 Due: 06/10/24

Combination Primary Care and Prevention Services for Women Who Inject Drugs and Exchange Sex in Seattle, Washington

Phase: N/A Priority: Normal

NCT ID: NCT06187064 Org: User:

Start: 03/18/24 End: 03/12/25 Due: 03/12/26

Firsthand ID for Pain Control

Phase: N/A Priority: Normal

NCT ID: NCT01823874 Org: User:

Start: 04/30/13 End: 12/31/13 Due: 12/31/14

CEP-1 Hormonal Regulation of Circulating Endothelial Progenitor Cells and HDL-C in Men

Phase: N/A Priority: Normal

NCT ID: NCT00729859 Org: User:

Start: 12/31/08 End: 05/31/10 Due: 05/31/11

PET Scans in Assessing Response To Treatment in Patients Receiving Hormone Therapy or Trastuzumab for Breast Cancer

Phase: N/A Priority: Normal

NCT ID: NCT00362973 Org: User:

Start: 05/31/06 End: - Due: -

Carotid Ultrasound Sub-Study of the Familial Atherosclerosis Study-observational Study

Phase: N/A Priority: Normal

NCT ID: NCT00976014 Org: User:

Start: 12/26/06 End: 05/09/12 Due: 05/09/13

Effects of Leader Sleep Improvement on Leadership

Phase: N/A Priority: Normal

NCT ID: NCT03014960 Org: User:

Start: 01/31/18 End: 06/30/18 Due: 06/30/19

CPNF Intervention Development and Testing

Phase: N/A Priority: Normal

NCT ID: NCT07036198 Org: User:

Start: 05/12/25 End: 09/01/27 Due: 09/01/28

Study of the Safety and Efficacy of Conivaptan (Vaprisol®) to Raise Serum Sodium Levels in Patients With Severe Traumatic Brain Injury

Phase: N/A Priority: Normal

NCT ID: NCT00930202 Org: User:

Start: 08/31/09 End: 06/30/10 Due: 06/30/11

Treatment for COVID-19 in High-Risk Adult Outpatients

Phase: N/A Priority: Normal

NCT ID: NCT04354428 Org: User:

Start: 04/16/20 End: 11/30/20 Due: 11/30/21

Evaluation of the Efficacy of the Becoming Parents Program

Phase: N/A Priority: Normal

NCT ID: NCT00243997 Org: User:

Start: 02/28/02 End: 05/31/08 Due: 05/31/09

Title	NCT ID	Organization	User	Status	Start Date	End Date	Reporting Due Date	Last Checked	User Role	Org Created
Immunomodulation Following Transfusion	NCT00810810	University of Washington	user2@example.com	None	2006-07-31	2011-08-31	2012-08-31	-	-	2025-07-14
Safer Conception Intervention for HIV-1 Serodiscordant Couples	NCT03030768	University of Washington	user2@example.com	None	2016-02-29	2018-07-31	2019-07-31	-	-	2025-07-14
Automated Real-time Feedback on CPR Study	NCT00539539	University of Washington	user2@example.com	None	2007-02-28	2009-09-30	2010-09-30	-	-	2025-07-14
A Study on the Use of Real -Time Continuous Glucose Monitoring (RT-CGM) in Gestational Diabetes	NCT04803357	University of Washington	user2@example.com	None	2021-04-10	2025-01-15	2026-01-15	-	-	2025-07-14
Daily Doxycycline for Early Syphillis	NCT06683638	University of Washington	user2@example.com	None	2025-03-03	2026-06-26	2027-06-26	-	-	2025-07-14
The Nociception Level During General Anesthesia	NCT01978379	University of Washington	user2@example.com	None	2013-10-31	2014-12-31	2015-12-31	-	-	2025-07-14
Breast Displacement and CT Radiation Dose	NCT01261559	University of Washington	user2@example.com	None	2010-12-31	2012-02-29	2013-02-28	-	-	2025-07-14
Hormone Replacement Therapy and Prothrombotic Variants	NCT00049933	University of Washington	user2@example.com	None	2002-09-30	2008-08-31	2009-08-31	-	-	2025-07-14
Text Messaging to Improve Adherence to Clinic Visits and Reduce Early Resumption of Sexual Intercourse After Male Circumcision	NCT01186575	University of Washington	user2@example.com	None	2010-08-31	2011-06-30	2012-06-30	-	-	2025-07-14
Durvalumab, Tremelimumab and Hypofractionated Radiation Therapy in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma	NCT03522584	University of Washington	user2@example.com	None	2018-05-17	2022-01-19	2023-01-19	-	-	2025-07-14
Umbralisib and Pembrolizumab in Treating Patients With Relapsed or Refractory Classical Hodgkin Lymphoma	NCT03776864	University of Washington	user2@example.com	None	2019-09-26	2021-09-14	2022-09-14	-	-	2025-07-14
Overcoming Barriers to HIV/AIDS Care and ART Initiation	NCT02718456	University of Washington	user2@example.com	None	2013-08-31	2017-12-22	2018-12-22	-	-	2025-07-14
Motivation Matters Study	NCT02627365	University of Washington	user2@example.com	None	2016-01-31	2018-08-31	2019-08-31	-	-	2025-07-14
Primary Care Obesity Prevention and Treatment	NCT00944164	University of Washington	user2@example.com	None	2006-09-30	2008-08-31	2009-08-31	-	-	2025-07-14
Dental Hygiene and Peri-Implant Tissues Homeostasis	NCT03384446	University of Washington	user2@example.com	None	2017-11-22	2023-06-10	2024-06-10	-	-	2025-07-14
Combination Primary Care and Prevention Services for Women Who Inject Drugs and Exchange Sex in Seattle, Washington	NCT06187064	University of Washington	user2@example.com	None	2024-03-18	2025-03-12	2026-03-12	-	-	2025-07-14
Firsthand ID for Pain Control	NCT01823874	University of Washington	user2@example.com	None	2013-04-30	2013-12-31	2014-12-31	-	-	2025-07-14
CEP-1 Hormonal Regulation of Circulating Endothelial Progenitor Cells and HDL-C in Men	NCT00729859	University of Washington	user2@example.com	None	2008-12-31	2010-05-31	2011-05-31	-	-	2025-07-14
PET Scans in Assessing Response To Treatment in Patients Receiving Hormone Therapy or Trastuzumab for Breast Cancer	NCT00362973	University of Washington	user2@example.com	None	2006-05-31	-	-	-	-	2025-07-14
Carotid Ultrasound Sub-Study of the Familial Atherosclerosis Study-observational Study	NCT00976014	University of Washington	user2@example.com	None	2006-12-26	2012-05-09	2013-05-09	-	-	2025-07-14
Effects of Leader Sleep Improvement on Leadership	NCT03014960	University of Washington	user2@example.com	None	2018-01-31	2018-06-30	2019-06-30	-	-	2025-07-14
CPNF Intervention Development and Testing	NCT07036198	University of Washington	user2@example.com	None	2025-05-12	2027-09-01	2028-09-01	-	-	2025-07-14
Study of the Safety and Efficacy of Conivaptan (Vaprisol®) to Raise Serum Sodium Levels in Patients With Severe Traumatic Brain Injury	NCT00930202	University of Washington	user2@example.com	None	2009-08-31	2010-06-30	2011-06-30	-	-	2025-07-14
Treatment for COVID-19 in High-Risk Adult Outpatients	NCT04354428	University of Washington	user2@example.com	None	2020-04-16	2020-11-30	2021-11-30	-	-	2025-07-14
Evaluation of the Efficacy of the Becoming Parents Program	NCT00243997	University of Washington	user2@example.com	None	2002-02-28	2008-05-31	2009-05-31	-	-	2025-07-14

Compliance Rate

My Organizations' Clinical Trials

Appearance